Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference12 articles.
1. Inc E. FYCOMPA (TM) oral tablets. Product information. In: Inc E, editor. Woodcliff Lake; 2012.
2. Eisai announces FDA approval of FYCOMPA® in pediatric patients as young as 4 years old for the treatment of partial-onset seizures [press release]. Woodcliff Lake: Eisai2018.
3. LaPenna P, Tormoehlen LM. The pharmacology and toxicology of third-generation anticonvulsant drugs. J Med Toxicol. 2017;13(4):329–42.
4. Greenwood J, Valdes J. Perampanel (Fycompa): a review of clinical efficacy and safety in epilepsy. P T. 2016;41(11):683–98.
5. Youn SE, Kim SH, Ko A, Lee SH, Lee YM, Kang HC, et al. Adverse events during perampanel adjunctive therapy in intractable epilepsy. J Clin Neurol. 2018;14(3):296–302.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献